🇺🇸 FDA
Company

Monopar

Monopar Therapeutics

MNPR pharma USA

Quick answer

Monopar is a pharma company (MNPR) headquartered in WILMETTE, IL, USA with 4 tracked pipeline programs.

Pipeline (4)

project

Clonidine HCl Mucoadhesive Buccal Tablet

Chemoradiotherapy-Induced Severe Oral Mucositis

Phase 3 · small_molecule · terminated

1 trials project

Camsirubicin

Advanced Soft-tissue Sarcoma

Phase 1 · small_molecule · terminated

1 trials project

MNPR-101-DFO*-89Zr

Solid Tumor, Adult

Phase 1 · small_molecule · active

1 trials project

MNPR-101-PCTA-177Lu

Solid Tumor, Adult

Phase 1 · small_molecule · active

1 trials

Patents (3)

patent

US 11090290

Clonidine and/or clonidine derivatives for use in the prevention of skin injury

Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10675271

Clonidine and/or clonidine derivatives for use in the prevention and/or treatmen

Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10450340

3′-deamino-3′-(2″-pyrroline-1″-yl)-5-imino-13-deoxyanthracyclines and methods of

Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)